Bausch + Lomb Corp's latest earnings report reveals stable performance amidst a challenging market landscape.
On July 29, 2026, Bausch + Lomb Corp (BLCO.TO) reported its second-quarter earnings for the period ending June 30, 2026. The company’s earnings per share (EPS) came in at CA$0.16, matching analyst expectations exactly, resulting in a surprise of 0.00%. The reported revenue of CA$1.39 billion also surpassed the consensus estimate, indicating a solid quarter for the health care equipment and supplies company.
Recent earnings trend
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeMarket cap
$8.14B
52W high
$25.70
52W low
$18.25
1W change
+5.69%
Beta
0.56
Analyst Price Targets
Based on analyst covering BLCO
Wall Street analysts forecast BLCO stock price to fall 20.9% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$18.79
-20.9% Upside
Current Price
C$23.76
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
35.8%
Annualized
90-Day Vol
31.2%
Annualized
Trend (90d)
+35.2%
Annualized drift
90d Mean
C$26.94
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$24.78 | C$21.90 – C$28.03 |
| 60 trading days | C$25.84 | C$21.70 – C$30.77 |
| 90 trading days | C$26.94 | C$21.75 – C$33.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 11 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 2 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-06-30 | 2026-07-29 | 0.1600 | 0.1600 | +0.0% |
| 2026-03-31 | 2026-04-29 | 0.0800 | 0.0600 | +33.3% |
| 2025-12-31 | 2026-02-18 | 0.3200 | 0.3600 | -11.1% |
| 2025-09-30 | 2025-10-29 | 0.1800 | 0.1600 | +12.5% |
| 2025-06-30 | 2025-07-30 | 0.0700 | 0.0900 | -22.2% |
| 2025-03-31 | 2025-04-30 | -0.0700 | 0.0200 | -450.0% |
Advertisement
Investor takeaway: While Bausch + Lomb's earnings met expectations, the company faces ongoing challenges in competitive markets, particularly in the premium IOL and dry eye segments. Investors should watch for future revenue growth and operational efficiency as key indicators of long-term performance.
Q2 2026 EPS Matches Estimates at CA$0.16
This quarter's EPS of CA$0.16 aligns with analyst forecasts, maintaining a steady performance amidst fluctuating market conditions and demonstrating the company's resilience.
Bull case
Bausch + Lomb has shown consistent revenue growth, with a year-over-year increase of 9%, reflecting strong demand across its product lines. The company is also improving its operational efficiency, highlighted by a 28% growth in adjusted EBITDA and expanding margins. The recent earnings report suggests that Bausch + Lomb is on track to meet its full-year revenue guidance, which is a positive sign for future performance.
Bear case
Despite meeting earnings expectations, Bausch + Lomb is facing competitive pressures and market challenges, especially in the premium IOL and dry eye sectors. The company is also working to regain customer trust after a recall, which could slow growth in the near term. Additionally, the stock has underperformed compared to the broader market, raising concerns about its long-term viability.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
